Dopamine-dependent behavioural stimulation by non-peptide delta opioids BW373U86 and SNC 80: 1. Locomotion, rearing and stereotypies in intact rats

Behavioural Pharmacology

Volumn 9, Issue 1, 1998, Pages 1-8

  Spina, L ^a   Longoni, R ^a   Mulas, A ^a   Chang, K J ^a,b   Di Chiara, G ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b DUKE UNIVERSITY   (United States)

Author keywords

Behaviour; BW373U86; Delta opioids; Dopamine; Locomotion; Rat; SNC 80; Stereotypies

Indexed keywords

4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 HYDROXYBENZYL] N,N DIETHYLBENZAMIDE; 4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DELTA OPIATE RECEPTOR AGONIST; DELTA OPIATE RECEPTOR ANTAGONIST; DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; NALOXONAZINE; NALTRINDOLE; RACLOPRIDE; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG EFFECT; GNAWING; INTRAPERITONEAL DRUG ADMINISTRATION; LICKING; LOCOMOTION; MALE; NONHUMAN; RAT; REARING; SNIFFING; STEREOTYPY; SUBCUTANEOUS DRUG ADMINISTRATION;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; BENZAMIDES; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MOTOR ACTIVITY; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, DELTA; STEREOTYPED BEHAVIOR; TIME FACTORS;

EID: 0031886523     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Bilsky EJ, Calderon SN, Wang T, Bernstein RN, Davis P, Hruby VJ et al. (1995). SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist. J Pharmacol Exp Ther 273:359-366.
2. Chang K-J, Cuatrecasas P (1981). Heterogeneity and properties of opiate receptors. Federation Proc 40:2729-2734.
3. Chang K-J, Rigdon GC, Howard JL, McNutt RW (1993). A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86. J Pharmacol Exp Ther 2670:852-857.
4. Comer SD, Hoenicke EM, Sable AI, McNutt RW, Chang K-J, De Costa BR et al. (1993). Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice. J Pharmacol Exp Ther 267:888-895.
5. Corbett AD, Gillan MGC, Kosterlitz HW, McKnight AT, Paterson SJ, Robson LE (1984). Selectivities of opioid peptide analogues as agonists and antagonists at the δ-receptor. Br J Pharmacol 83:271-279.
6. Di Chiara G, Gessa GE (1978). Pharmacology and neurochemistry of apomorphine. Adv Pharmacol Chemother 15:87-160.
7. Erspamer V, Melchiorri P, Falconieri-Erspamer G, Negri L, Corsi R, Severini C et al. (1989). Deltorphins: a family of naturally occurring peptides with high affinity and selectivity for δ-opioid binding sites. Proc Natl Acad Sci USA 86:5188-5192.
8. Evans CJ, Keith DE, Morrison H, Magendzo K, Edwards RH (1992). Cloning of a delta opioid receptor by functional expression. Science 258:1952-1954.
9. Hyttel J (1983). SCH 23390 - the first selective dopamine D1 antagonist. Eur J Pharmacol 91:153-154.
10. Iorio LC, Barnett A, Leitz FH, Houser VP, Korduba CA (1983). SCH 23390, a potential henzazepine antipsychotic with unique interactions on dopaminergic systems. J Pharmacol Exp Ther 226:462-468.
11. Kieffer BL, Befort K, Gaveriaux-Ruff C, Hirth CG (1992). The δ-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc Natl Acad Sci USA 89:12048-12052.
12. Kreil G, Barra D, Simmaco M, Erspamer V, Falconieri-Erspamer G, Negri L et al. (1989). Deltorphin, a novel amphibian skin peptide with high selectivity and affinity for delta opioid receptors, Eur J Pharmacol 162:123-128.
13. 1-dependent stereotypies and stimulation of dopamine release in the nucleus accumbens. J Neurosci 11:1565-1576.
14. Longoni R, Cadoni C, Mulas A, Di Chiara G, Spina L (1998). Dopamine-dependent behavioural stimulation by non-peptide delta opioid BW 373U86 and SNC 80: 2. Place-preference and brain dialysis studies. Behav Pharmacol 9:9-14.
15. Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ (1987). Autoradiographic differentiation of Mu. Delta and Kappa opioid receptors in the rat forebrain and midbrain. J Neurosci 7:2445-2464.
16. 1 dopamine receptors. Brain Res (in press).
17. Mosberg HI. Omnaas JR, Goldstein A (1987). Structural requirements for δ-opioid receptor binding. Mol Pharmacol 31:599-602.
18. Negri L, Noviello V, Angelucci F (1991). Behavioural effects of deltorphins in rats. Eur J Pharmacol 209:163-168.
19. 2 responses in unilaterally 6-hydroxy dopamine-lesioned rats. Behav Pharmacol 9:15-22.
20. Portoghese PS, Sultana M, Takemori AE (1988). Naltrindole, a highly selective and potent nonpeptide δ-opioid receptor antagonist. Eur J Pharmacol 146:185-186.
21. Wood PL (1982). Multiple opiate receptors: support for unique mu, delta and kappa sites. Neuropharmacology 21 : 487-497.
22. Zukin RS, Zukin SR (1984). The case for multiple opiate receptors. Trends Neurosci 7:160-164.